Part I: testicular cancer--management of early disease (Q35603097)

9 August 2017

1 reference

title

Part I: testicular cancer--management of early disease (English)

1 reference

9 August 2017

Robert H Jones

1

1 reference

9 August 2017

Paul A Vasey

series ordinal

2

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Lancet Oncology Commission

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

730-737

1 reference

Carcinoma in situ of the testis: review of biological and clinical features

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

New directions in testicular cancer; molecular determinants of oncogenesis and treatment success

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Decrease in testosterone blood concentrations after testicular sperm extraction for intracytoplasmic sperm injection in azoospermic men

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Pilot Study to Evaluate Impact of a Policy of Adjuvant Chemotherapy for High Risk Stage 1 Malignant Teratoma on Overall Relapse Rate of Stage 1 Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Late toxicity following curative treatment of testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Late relapse of germ cell tumors after cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Late Relapse of Clinical Stage I Testicular Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Surgical treatment of stage-I non-seminomatous germ cell testis tumor. Final results of a prospective multicenter trial 1982-1987. Testicular Tumor Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Surveillance following orchidectomy for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Surveillance after orchiectomy for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Orchidectomy alone for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

Fluorodeoxyglucose PET in the initial staging of germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901278-6

7 January 2021

10.1016/S1470-2045(03)01278-6

Identifiers

DOI

1 reference

9 August 2017

1 reference